(Q33509317)

27 July 2017

Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: a model of sporadic Alzheimer's disease (English)

1 reference

27 July 2017

0 references

5

B Tomanek

1 reference

27 July 2017

M Labak

1

1 reference

27 July 2017

T Foniok

2

1 reference

27 July 2017

D Kirk

3

1 reference

27 July 2017

D Rushforth

4

1 reference

27 July 2017

A Jasiński

6

1 reference

27 July 2017

P Grieb

7

1 reference

27 July 2017

1 January 2010

1 reference

Acta Neurochirurgica. Supplementum

27 July 2017

1 reference

27 July 2017

106

1 reference

27 July 2017

177-181

1 reference

Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein.

27 July 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Glutamatergic neurotransmission and neuronal glucose oxidation are coupled during intense neuronal activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

Correlation between choline signal intensity and acetylcholine level in different brain regions of rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-98811-4_32

10.1007/978-3-211-98811-4_32

31 March 2020

Identifiers

DOI

1 reference

27 July 2017

1 reference